Tag: clinical studies

July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
May 10, 2018

Namaste Signs Agreement for 51 Percent Stake in Infinite Labz

Namaste Technologies signed a share purchase agreement to acquire 51 percent of the outstanding shares of Infinite Labz and has...
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 9, 2018

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International LLC (CSE:ISOL, OTC:ISOLF, FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and...
May 8, 2018

Madrigal Pharmaceuticals Reports 2018 First Quarter Financial Results and Reviews Key Clinical Achievements

Madrigal Pharmaceuticals (NASDAQ:MDGL) today announced its first quarter 2018 financial results. As quoted in the press release: “The results to...
May 8, 2018

scPharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

scPharmaceuticals (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of...
May 7, 2018

Scythian Biosciences Announces Licensing Agreement With Isodiol International Inc.

Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that it has...